COVID-19 treatment

NEW DELHI (Reuters) – Two Indian drugmakers have requested permission to end late-stage trials of their generic versions of Merck

CARACAS (Reuters) – Venezuelans are increasingly relying on friends and strangers to help pay for COVID-19 treatment as hyperinflation and